STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] BRF S.A. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Amendment No. 1 to Schedule 13D reports that SALIC Investment executed a public sale of 185,556,900 common shares of BRF S.A. at a net price of approximately R$19.96 per share via an auction on B3, which settled on September 4, 2025. Concurrent with the sale, SALIC entered a cash-settled derivative referencing the same 185,556,900 shares with an unaffiliated dealer, including an upfront payment by SALIC and ongoing non-refundable fees. The derivative permits SALIC to elect cash settlement prior to expiry and is scheduled to expire on September 2, 2026. As a result of the disposition, the reporting persons ceased to be beneficial owners of more than 5% of BRF common shares.

Positive
  • Large, orderly disposition of 185,556,900 shares via an auction on B3 at an identified net price of R$19.96 per share
  • Full disclosure of the concurrent cash-settled derivative and its key commercial features, including upfront payment and expiry date of September 2, 2026
Negative
  • Reporting persons ceased to be beneficial owners of more than 5% of BRF common shares, indicating reduced disclosed influence
  • Derivative retains potential economic exposure despite the disposition, which may complicate assessments of actual change in economic interest

Insights

TL;DR Sale of 185,556,900 BRF shares and a linked cash-settled derivative reduced SALIC's holdings below 5%, removing its >5% beneficial ownership status.

The filing documents a material disposition: 185,556,900 shares sold at ~R$19.96 per share settled September 4, 2025. The concurrent cash-settled derivative references the identical share amount, includes an upfront payment and quarterly fees, and allows SALIC to trigger cash settlement prior to an expiry currently set for September 2, 2026. The structure suggests SALIC retained economic exposure via the derivative while transferring legal ownership. The reporting persons now report 0% beneficial ownership on the cover pages.

TL;DR Reporting persons formally relinquished >5% beneficial ownership while documenting a structured derivative tied to the disposed shares.

The amendment clarifies that the Reporting Persons executed a disposition through an auction and concurrently entered a cash-settled derivative with a dealer. The derivative involves upfront and quarterly non-refundable payments and contemplates cash settlement either upon exercise or at expiry on September 2, 2026. The filing discloses cessation of >5% beneficial ownership but continues to record the derivative relationship, which is relevant for governance and disclosure because it preserves potential economic exposure despite the disposition.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
Sovereign Wealth Fund of Saudi Arabia


SCHEDULE 13D


SALIC International Investment Company
Signature:/s/ Sulaiman AlRumaih
Name/Title:Sulaiman AlRumaih, Chief Executive Officer
Date:09/04/2025
Saudi Agricultural and Livestock Investment Company
Signature:/s/ Sulaiman AlRumaih
Name/Title:Sulaiman AlRumaih, Chief Executive Officer
Date:09/04/2025
The Public Investment Fund
Signature:/s/ Yasir O. AlRumayyan
Name/Title:Yasir O. AlRumayyan, Governor
Date:09/04/2025

FAQ

What did SALIC sell in the BRFS filing?

SALIC sold 185,556,900 common shares of BRF S.A. at a net price of approximately R$19.96 per share via an auction on B3.

When did the BRFS transaction settle?

The sale settled on September 4, 2025 as stated in the Schedule 13D amendment.

Did the reporting persons keep any exposure to BRF after the sale?

Yes. Substantially concurrently, SALIC entered a cash-settled derivative referencing the same 185,556,900 shares, with an expiry of September 2, 2026.

Do the reporting persons still own more than 5% of BRF (BRFS)?

No. The filing states that as a result of the disposition, the reporting persons ceased to be beneficial owners of more than 5% of the outstanding common shares.

What are the payment terms for the derivative in the BRFS filing?

SALIC agreed to an upfront payment based on the initial reference price for 185,556,900 shares and certain other non-refundable fees payable upfront and on a quarterly basis.
BRF SA

NYSE:BRFS

BRFS Rankings

BRFS Latest News

BRFS Latest SEC Filings

BRFS Stock Data

5.38B
752.17M
53.04%
3.84%
0.84%
Packaged Foods
Consumer Defensive
Link
Brazil
São Paulo